Free Trial

Mesoblast (MESO) Short Interest Ratio & Short Volume

Mesoblast logo
$13.30 -0.55 (-3.97%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$13.38 +0.07 (+0.56%)
As of 03/27/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mesoblast Short Interest Data

Mesoblast (MESO) has a short interest of 2.65 million shares, representing 2.57% of the float (the number of shares available for trading by the public). This marks a 6.85% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.5, indicating that it would take 5.5 days of the average trading volume of 437,037 shares to cover all short positions.

Current Short Interest
2,650,000 shares
Previous Short Interest
2,480,000 shares
Change Vs. Previous Month
+6.85%
Dollar Volume Sold Short
$35.91 million
Short Interest Ratio
5.5 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
127,053,000 shares
Short Percent of Float
2.57%
Today's Trading Volume
253,665 shares
Average Trading Volume
437,037 shares
Today's Volume Vs. Average
58%
Short Selling Mesoblast?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Mesoblast and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MESO Short Interest Over Time

MESO Days to Cover Over Time

MESO Percentage of Float Shorted Over Time

Remove Ads

Mesoblast Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20252,650,000 shares $35.91 million +6.9%2.6%5.5 $13.55
2/28/20252,480,000 shares $42.53 million +9.7%2.4%5.2 $17.15
2/15/20252,260,000 shares $40.45 million +10.8%2.2%5.1 $17.90
1/31/20252,040,000 shares $41.09 million +9.7%N/A4.5 $20.14
1/15/20251,860,000 shares $31.81 million +3.3%N/A4.4 $17.10
12/31/20241,800,000 shares $35.64 million +34.3%N/A4.7 $19.80
12/15/20241,340,000 shares $15.76 million -5.6%N/A4 $11.76
11/30/20241,420,000 shares $16.60 million -15.5%N/A7.1 $11.69
11/15/20241,680,000 shares $16.87 million +20.9%N/A9 $10.04
10/31/20241,390,000 shares $11.65 million +11.2%N/A9.1 $8.38
10/15/20241,250,000 shares $12.03 million +34.3%N/A7.9 $9.62
9/30/2024931,100 shares $7.61 million -7.8%N/A5.3 $8.17
9/15/20241,010,000 shares $6.28 million +20.5%N/A6.4 $6.22
8/31/2024838,200 shares $5.65 million +9.1%N/A5.3 $6.74
8/15/2024768,300 shares $4.92 million +15.7%N/A4.5 $6.40
7/31/2024663,800 shares $4.49 million +77.8%N/A3.5 $6.77
7/15/2024373,300 shares $2.86 million -18.9%N/A1.7 $7.65
6/30/2024460,500 shares $3.14 million -2.2%N/A1.8 $6.81
6/15/2024470,900 shares $3.43 million -6.0%N/A0.2 $7.28
5/31/2024500,800 shares $3.73 million -36.0%N/A0.2 $7.44
5/15/2024781,900 shares $5.63 million -12.8%N/A0.4 $7.20
4/30/2024896,400 shares $5.92 million +25.2%N/A0.4 $6.60
4/15/2024716,100 shares $3.70 million -69.4%N/A0.3 $5.17
3/31/20242,340,000 shares $11.72 million +190.1%N/A1.1 $5.01
3/15/2024806,500 shares $1.96 million +59.2%N/A0.5 $2.43
2/29/2024506,600 shares $995,469.00 -6.8%N/A1.2 $1.97
2/15/2024543,500 shares $1.10 million -9.7%N/A2.7 $2.03
1/31/2024601,900 shares $1.06 million +23.0%N/A3.2 $1.76
1/15/2024489,400 shares $954,330.00 -22.8%N/A2.5 $1.95
12/31/2023633,600 shares $1.39 million -17.8%N/A4.2 $2.20
12/15/2023771,200 shares $825,184.00 +16.4%N/A2.7 $1.07
11/30/2023662,600 shares $901,136.00 -9.7%N/A4.6 $1.36
11/15/2023734,100 shares $946,989.00 +5.1%N/A5.1 $1.29
10/31/2023698,600 shares $852,292.00 +2.3%N/A2.6 $1.22
10/15/2023683,200 shares $840,336.00 -22.0%N/A1.5 $1.23
9/30/2023876,300 shares $1.08 million -6.9%N/A1.7 $1.23
9/15/2023941,200 shares $1.34 million -15.2%N/A1.8 $1.42
8/31/20231,110,000 shares $1.79 million -51.5%N/A2.1 $1.61
8/15/20232,290,000 shares $2.91 million +76.2%N/A4.6 $1.27
7/31/20231,300,000 shares $5.20 million +107.4%N/A3.3 $4.00
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
7/15/2023626,800 shares $3.01 million +52.1%N/A3.2 $4.80
6/30/2023412,000 shares $1.61 million -9.8%N/A2.9 $3.91
6/15/2023456,600 shares $1.68 million +5.9%N/A3.8 $3.68
5/31/2023431,100 shares $1.46 million -6.0%N/A3.7 $3.38
5/15/2023458,400 shares $1.70 million -14.8%N/A3.7 $3.70
4/30/2023537,900 shares $1.59 million +29.0%N/A3.7 $2.95
4/15/2023416,900 shares $1.43 million +13.4%N/A3.1 $3.44
3/31/2023367,500 shares $1.21 million +7.8%N/A2.5 $3.29
3/15/2023341,000 shares $1.06 million -54.2%N/A2.3 $3.12
2/28/2023745,100 shares $2.46 million +12.9%N/A4.5 $3.30
2/15/2023659,900 shares $2.29 million +45.3%N/A4.5 $3.47
1/31/2023454,200 shares $1.50 million +7.5%N/A3.3 $3.30
1/15/2023422,700 shares $1.39 million +2.5%N/A3.7 $3.28
12/30/2022412,400 shares $1.20 million -27.6%N/A3.8 $2.91
12/15/2022569,800 shares $1.78 million +10.9%N/A5.7 $3.13
11/30/2022513,700 shares $1.90 million -2.1%N/A6.5 $3.70
11/15/2022524,800 shares $1.72 million -2.6%N/A8 $3.27
10/31/2022538,600 shares $1.57 million -4.2%N/A8.7 $2.91
10/15/2022561,900 shares $1.75 million +8.9%N/A8.4 $3.11
9/30/2022516,000 shares $1.31 million +3.5%N/A7.4 $2.55
9/15/2022498,800 shares $1.59 million -0.6%N/A6.9 $3.19
8/31/2022501,700 shares $1.49 million +2.0%N/A6.7 $2.96
8/15/2022491,900 shares $1.56 million +0.2%N/A6.6 $3.17
7/31/2022490,700 shares $1.64 million -4.8%N/A6.4 $3.34
7/15/2022515,600 shares $1.49 million -13.6%N/A7.3 $2.89
6/30/2022596,400 shares $1.32 million -7.2%N/A8.4 $2.22
6/15/2022642,300 shares $1.52 million -0.1%N/A9.3 $2.37
5/31/2022643,000 shares $2.26 million -26.1%N/A8.8 $3.51
5/15/2022869,500 shares $3.07 million -5.2%N/A11.9 $3.53
4/30/2022917,500 shares $3.37 million -11.8%N/A13.3 $3.67
4/15/20221,040,000 shares $4.47 million -2.8%N/A13.8 $4.30
3/31/20221,070,000 shares $4.52 million -7.0%N/A14.2 $4.22
3/15/20221,150,000 shares $5.03 million -0.9%N/A11.5 $4.37
2/28/20221,160,000 shares $4.51 million -2.5%N/A6.2 $3.89
2/15/20221,190,000 shares $4.84 million -0.8%N/A5.9 $4.07
1/31/20221,200,000 shares $4.85 million +2.6%N/A5.5 $4.04
1/15/20221,170,000 shares $5.42 million +2.6%N/A5.3 $4.63
12/31/20211,140,000 shares $5.47 million +1.8%N/A5.1 $4.80
12/15/20211,120,000 shares $5.57 million -8.2%N/A5.2 $4.97
11/30/20211,220,000 shares $7.38 million +1.7%N/A8.1 $6.05
11/15/20211,200,000 shares $8.51 million -1.6%N/A7.9 $7.09
10/29/20211,220,000 shares $7.38 million +9.9%N/A9 $6.05
10/15/20211,110,000 shares $6.30 million -10.5%N/A8.4 $5.68
9/30/20211,240,000 shares $7.45 million No ChangeN/A9.7 $6.01
9/15/20211,240,000 shares $7.87 million -23.9%N/A9.5 $6.35
8/31/20211,630,000 shares $10.64 million +5.8%N/A10.6 $6.53
8/13/20211,540,000 shares $11.58 million No ChangeN/A11.9 $7.52
7/30/20211,540,000 shares $10.78 million +4.8%N/A10.9 $7.00
7/15/20211,470,000 shares $10.88 million +2.8%N/A6.7 $7.40
6/30/20211,430,000 shares $10.70 million +8.3%N/A6.4 $7.48
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
6/15/20211,320,000 shares $10.86 million -0.8%N/A5.6 $8.23
5/28/20211,330,000 shares $10.28 million -2.2%N/A6.1 $7.73
5/14/20211,360,000 shares $9.15 million -2.9%N/A5.8 $6.73
4/30/20211,400,000 shares $10.11 million +6.1%N/A4.5 $7.22
4/15/20211,320,000 shares $11.48 million +10.0%N/A4.8 $8.70
3/31/20211,200,000 shares $9.91 million -18.9%N/A2 $8.26
3/15/20211,480,000 shares $13.81 million -21.3%N/A2 $9.33
2/26/20211,880,000 shares $18.05 million -33.3%N/A2.5 $9.60
2/12/20212,820,000 shares $30.88 million -10.2%N/A3.4 $10.95
1/29/20213,140,000 shares $28.92 million -15.8%N/A4 $9.21
1/15/20213,730,000 shares $36.67 million +11.0%N/A4.8 $9.83
12/31/20203,360,000 shares $28.66 million +8.0%N/A4.4 $8.53
12/15/20203,110,000 shares $52.53 million -0.3%N/A5 $16.89
11/30/20203,120,000 shares $46.58 million -4.9%N/A5.7 $14.93
11/15/20203,280,000 shares $38.97 million +0.9%N/A5.2 $11.88
10/30/20203,250,000 shares $35.43 million +8.7%N/A3 $10.90
10/15/20202,990,000 shares $35.46 million -4.8%N/A2.5 $11.86
9/30/20203,140,000 shares $58.36 million +18.1%N/A2.7 $18.59
9/15/20202,660,000 shares $47.08 million +21.5%N/A2.5 $17.70
8/31/20202,190,000 shares $42.40 million +7.9%N/A2.1 $19.36
8/14/20202,030,000 shares $36.30 million +25.3%N/A2 $17.88
7/31/20201,620,000 shares $21.74 million +14.1%N/A2.9 $13.42
7/15/20201,420,000 shares $16.26 million +19.3%N/A1.3 $11.45
6/30/20201,190,000 shares $12.98 million +26.8%N/A1 $10.91
6/15/2020938,400 shares $11.53 million +11.9%N/A0.8 $12.29
5/29/2020838,700 shares $10.61 million -28.3%N/A0.7 $12.65
5/15/20201,170,000 shares $14.39 million +10.4%N/A1.1 $12.30
4/30/20201,060,000 shares $11.63 million +76.6%N/A1.1 $10.98
4/15/2020600,400 shares $4.42 million +158.6%N/A0.8 $7.36
3/31/2020232,200 shares $3.59 million +46.4%N/A1.2 $15.45

MESO Short Interest - Frequently Asked Questions

What is Mesoblast's current short interest?

Short interest is the volume of Mesoblast shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 2,650,000 shares of MESO short. 2.57% of Mesoblast's shares are currently sold short. Learn More on Mesoblast's current short interest.

What is a good short interest ratio for Mesoblast?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MESO shares currently have a short interest ratio of 6.0. Learn More on Mesoblast's short interest ratio.

Which institutional investors are shorting Mesoblast?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mesoblast: Group One Trading LLC, Citadel Advisors LLC, Susquehanna International Group LLP, Affinity Asset Advisors LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Mesoblast?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.57% of Mesoblast's floating shares are currently sold short.

Is Mesoblast's short interest increasing or decreasing?

Mesoblast saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,650,000 shares, an increase of 6.9% from the previous total of 2,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Mesoblast's short interest compare to its competitors?

2.57% of Mesoblast's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Mesoblast: BridgeBio Pharma, Inc. (15.19%), Lantheus Holdings, Inc. (9.73%), TG Therapeutics, Inc. (18.55%), Legend Biotech Co. (6.24%), Axsome Therapeutics, Inc. (12.98%), Blueprint Medicines Co. (8.20%), Krystal Biotech, Inc. (10.93%), Nuvalent, Inc. (12.38%), Cytokinetics, Incorporated (12.32%), Verona Pharma plc (12.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Mesoblast stock?

Short selling MESO is an investing strategy that aims to generate trading profit from Mesoblast as its price is falling. MESO shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mesoblast?

A short squeeze for Mesoblast occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MESO, which in turn drives the price of the stock up even further.

How often is Mesoblast's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MESO, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:MESO) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners